FI922773A0 - Nya p-substituerade fenyl-4- oksibutanaminderivat, foerfarande foer deras framstaelllning samt farmaceutiska kompositioner innehaollande desamma. - Google Patents

Nya p-substituerade fenyl-4- oksibutanaminderivat, foerfarande foer deras framstaelllning samt farmaceutiska kompositioner innehaollande desamma.

Info

Publication number
FI922773A0
FI922773A0 FI922773A FI922773A FI922773A0 FI 922773 A0 FI922773 A0 FI 922773A0 FI 922773 A FI922773 A FI 922773A FI 922773 A FI922773 A FI 922773A FI 922773 A0 FI922773 A0 FI 922773A0
Authority
FI
Finland
Prior art keywords
oxybutanaminderivat
framstaelllning
substituerade
fenyl
nya
Prior art date
Application number
FI922773A
Other languages
English (en)
Other versions
FI922773A (fi
Inventor
Paule Bonnet
Remi Delansorne
Maurice Faure
Michel Lanquetin
Serge Zunino
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theramex filed Critical Theramex
Publication of FI922773A0 publication Critical patent/FI922773A0/fi
Publication of FI922773A publication Critical patent/FI922773A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
FI922773A 1990-10-17 1992-06-16 Nya p-substituerade fenyl-4- oksibutanaminderivat, foerfarande foer deras framstaelllning samt farmaceutiska kompositioner innehaollande desamma. FI922773A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR909012562A FR2668150B1 (fr) 1990-10-17 1990-10-17 Nouveaux derives du terbutylphenyl 1-amino 4-hydroxybutane, leurs procedes de preparation et les compositions pharmaceutiques en renfermant.
PCT/FR1991/000811 WO1992006977A1 (fr) 1990-10-17 1991-10-17 NOUVEAUX DERIVES p-SUBSTITUES DE PHENYL 4-OXYBUTANE AMINE, LEURS PROCEDES DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES EN RENFERMANT

Publications (2)

Publication Number Publication Date
FI922773A0 true FI922773A0 (fi) 1992-06-16
FI922773A FI922773A (fi) 1992-06-16

Family

ID=9401134

Family Applications (1)

Application Number Title Priority Date Filing Date
FI922773A FI922773A (fi) 1990-10-17 1992-06-16 Nya p-substituerade fenyl-4- oksibutanaminderivat, foerfarande foer deras framstaelllning samt farmaceutiska kompositioner innehaollande desamma.

Country Status (23)

Country Link
US (1) US5461059A (fi)
EP (1) EP0505543A1 (fi)
JP (1) JPH05503298A (fi)
KR (1) KR927003589A (fi)
AP (1) AP282A (fi)
BG (1) BG60680B1 (fi)
BR (1) BR9106188A (fi)
CA (1) CA2071911A1 (fi)
CZ (1) CZ182292A3 (fi)
FI (1) FI922773A (fi)
FR (2) FR2668150B1 (fi)
HU (1) HUT61297A (fi)
IE (1) IE913636A1 (fi)
IL (1) IL99776A0 (fi)
MA (1) MA22321A1 (fi)
NO (1) NO922358L (fi)
NZ (1) NZ240274A (fi)
OA (1) OA09835A (fi)
PL (2) PL169022B1 (fi)
PT (1) PT99266A (fi)
RO (1) RO108241B1 (fi)
WO (1) WO1992006977A1 (fi)
ZA (1) ZA918282B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2048109B1 (es) * 1992-07-20 1994-12-16 Espanola Prod Quimicos Procedimiento de preparacion de nuevos derivados piperidicos del bencimidazol.
WO1994027973A1 (fr) * 1993-05-20 1994-12-08 Kissei Pharmaceutical Co., Ltd. Derive 1-(2-benzimidazolyl)-1,5-diazacyclooctane
ES2072193B1 (es) * 1993-05-21 1996-02-16 Espanola Prod Quimicos Nuevos derivados del1-fenilmetil bencimidazol piperacinas.
US5691323A (en) * 1995-05-12 1997-11-25 Merck & Co., Inc. Muscarine antagonists
FR2727865B1 (fr) * 1994-12-08 1997-07-18 Esteve Labor Dr Utilisation des derives de 2-(4-(azolybutyl)-piperazinyl- (methyl))-benzimidazole et analogues ainsi que de leurs sels, pour la preparation de medicaments destines au traitement ou a la prophylaxie de l'asthme
AU707139B2 (en) * 1996-04-03 1999-07-01 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
HUP0301622A3 (en) * 2000-07-04 2006-05-29 Novo Nordisk As Purine derivatives inhibiting the enzyme dipeptidyl petidase iv (dpp-iv) and pharmaceutical compositions containing them
WO2004009091A1 (en) * 2002-06-17 2004-01-29 Glaxo Group Limited Purine derivatives as liver x receptor agonists

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL137020C (fi) * 1962-08-31
US3161645A (en) * 1962-12-18 1964-12-15 Res Lab Dr C Janssen N V 1-(1-aroylpropyl-4-piperidyl)-2-benzimidazolinones and related compounds
US3491103A (en) * 1963-12-19 1970-01-20 Sandoz Ag Certain 4h-benzo(4,5)cyclohepta-(1,2-b) thiophenes
US4219559A (en) * 1979-01-10 1980-08-26 Janssen Pharmaceutica N.V. N-Heterocyclyl-4-piperidinamines
JPS5879983A (ja) * 1981-11-06 1983-05-13 Kanebo Ltd 新規なベンズイミダゾ−ル誘導体、その製造法およびその医薬組成物
US4695575A (en) * 1984-11-13 1987-09-22 Janssen Pharmaceutica, N.V. 4-[(bicycle heterocyclyl)-methyl and -hetero]-piperidines
NZ223654A (en) * 1987-03-09 1990-03-27 Janssen Pharmaceutica Nv 1-alkyl-substituted-benzimidazole-4-piperidinamines and pharmaceutical compositions
EP0339978B1 (en) * 1988-04-28 1996-08-21 Schering Corporation Fused polycyclic compounds, compositions, methods of manufacture, and their use as PAF antagonists, antihistamines and/or antiinflammatory agents
US4908372A (en) * 1988-10-13 1990-03-13 Merrell Dow Pharmaceuticals Inc. Antihistaminic piperidinyl benzimidazoles
PH30434A (en) * 1989-04-07 1997-05-09 Janssen Pharmaceutica Nv Hydroxyalkylfuranyl derivatives
US5217980A (en) * 1990-07-19 1993-06-08 Janssen Pharmaceutica N.V. Oxazolyl and piperidinyl substituted benimidazolyl compounds

Also Published As

Publication number Publication date
WO1992006977A1 (fr) 1992-04-30
HU9202176D0 (en) 1992-10-28
FR2670783B1 (fr) 1994-11-18
CA2071911A1 (fr) 1992-04-18
NO922358L (no) 1992-08-11
BR9106188A (pt) 1993-03-16
CZ182292A3 (en) 1993-01-13
KR927003589A (ko) 1992-12-18
AP282A (en) 1993-09-08
RO108241B1 (ro) 1994-03-31
OA09835A (fr) 1994-08-15
JPH05503298A (ja) 1993-06-03
PL169022B1 (pl) 1996-05-31
FR2668150A1 (fr) 1992-04-24
NZ240274A (en) 1995-07-26
NO922358D0 (no) 1992-06-16
PT99266A (pt) 1992-08-31
IL99776A0 (en) 1992-08-18
MA22321A1 (fr) 1992-07-01
BG60680B1 (bg) 1995-12-29
IE913636A1 (en) 1992-04-22
ZA918282B (en) 1992-07-29
EP0505543A1 (fr) 1992-09-30
PL169452B1 (pl) 1996-07-31
AP9100328A0 (en) 1991-10-31
FR2670783A1 (fr) 1992-06-26
FI922773A (fi) 1992-06-16
HUT61297A (en) 1992-12-28
US5461059A (en) 1995-10-24
FR2668150B1 (fr) 1994-11-18

Similar Documents

Publication Publication Date Title
FI913963A0 (fi) Nya bensimidazolderivat.
FI900313A0 (fi) Nya benzopyranderivat, deras framstaellning och dessa innehaollande farmaceutiska preparat.
FI920279A (fi) Nya sulfonylurea-foereningar.
FI902780A0 (fi) Nya poly-a-olefiner.
FI915400A (fi) Nya tricykliska foereningar.
FI914319A0 (fi) Nya karbocykliska adenosinanaloger anvaendbara som immunosupressanter.
FI894629A (fi) Nya 3,4-diaminokinolin- och -pyridinfoereningar.
FI873798A (fi) Aminoglykosidsteroider, foerfarande foer deras framstaellning, deras anvaendning samt farmaceutiska kompositioner innehaollande desamma.
FI913407A0 (fi) Nya purinderivat.
FI923762A0 (fi) Nya heparinderivat.
FI914513A0 (fi) Nya substituerade alkylamidderivat av teikoplanin.
FI914071A0 (fi) Nya hetrazepinoida amider.
FI873799A (fi) Aminoglykosidsteroider, foerfarande foer deras framstaellning, deras anvaendning samt farmaceutiska kompositioner innehaollande desamma.
FI902602A0 (fi) Nya foereningar.
FI922773A (fi) Nya p-substituerade fenyl-4- oksibutanaminderivat, foerfarande foer deras framstaelllning samt farmaceutiska kompositioner innehaollande desamma.
FI904191A0 (fi) Nya aminopropanolderivater, foerfarande foer tillverkning av dessa samt farmaceutiska sammansaettningar som innehaoller dessa.
FI911351A (fi) Nya 8-sulfamylmetylen-2 -aminotetraliner.
FI912317A (fi) Nya tricykliska foereningar.
FI904570A0 (fi) Foerfarande foer framstaellning av nya alkanofenoner.
FI901775A0 (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara tiouracilderivat.
FI904903A0 (fi) Nya foereningar.
FI915935A0 (fi) Nya cyklodextrininklusionskomplexer.
FI911508A (fi) Nya isokromanderivat.
FI901137A0 (fi) Nya foereningar.
FI905685A0 (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara alkoximetylidenepipodofyllotoxinglukosider.

Legal Events

Date Code Title Description
FD Application lapsed